title: Hydroxyurea use in patients with sickle cell disease in a Medicaid population.
authors.affiliation: Department of Pharmaceutical Outcomes and Policy, University of Florida, College of Pharmacy, Gainesville, Florida, USA.
authors.forename: Jane
authors.initials: J
authors.lastname: Ritho
authors.forename: Huazhi
authors.initials: H
authors.lastname: Liu
authors.forename: Abraham G
authors.initials: AG
authors.lastname: Hartzema
authors.forename: Richard
authors.initials: R
authors.lastname: Lottenberg
mesh_terms: D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000453:epidemiology; D000986:Antisickling Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D005260:Female; D005431:Florida / Q000453:epidemiology; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D008297:Male; D008484:Medicaid / Q000706:statistics & numerical data; D008875:Middle Aged; D012189:Retrospective Studies; D014481:United States; D055815:Young Adult
chemical_list: D000986:Antisickling Agents; D006918:Hydroxyurea